Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
暂无分享,去创建一个
[1] M. Ballmaier,et al. High Frequencies of Polyfunctional CD8+ NK Cells in Chronic HIV-1 Infection Are Associated with Slower Disease Progression , 2014, Journal of Virology.
[2] Xin Geng,et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection , 2013, Nature.
[3] E. Riley,et al. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease , 2013, Front. Immunol..
[4] M. Altfeld,et al. Control of human viral infections by natural killer cells. , 2013, Annual review of immunology.
[5] B. Gazzard,et al. Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral load. , 2013, AIDS research and human retroviruses.
[6] P. Carrega,et al. Natural killer cell distribution and trafficking in human tissues , 2012, Front. Immun..
[7] Nupur Bhatnagar,et al. Loss of CCR7 Expression on CD56bright NK Cells Is Associated with a CD56dimCD16+ NK Cell-Like Phenotype and Correlates with HIV Viral Load , 2012, PloS one.
[8] P. J. Norris,et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection , 2011, Proceedings of the National Academy of Sciences.
[9] J. Reynes,et al. Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. , 2011, Blood.
[10] Susan Moir,et al. Pathogenic mechanisms of HIV disease. , 2011, Annual review of pathology.
[11] H. Ljunggren,et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus , 2011, The Journal of experimental medicine.
[12] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[13] D. Mavilio,et al. Pathologic natural killer cell subset redistribution in HIV‐1 infection: new insights in pathophysiology and clinical outcomes , 2010, Journal of leukocyte biology.
[14] H. Pircher,et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.
[15] H. Ljunggren,et al. CD56 negative NK cells: origin, function, and role in chronic viral disease. , 2010, Trends in immunology.
[16] M. Ballmaier,et al. Phenotypically and functionally distinct subsets contribute to the expansion of CD56−/CD16+ natural killer cells in HIV infection , 2010, AIDS.
[17] Joseph A Conrad,et al. Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo. , 2010, Blood.
[18] S. Paludan,et al. Innate immune recognition and activation during HIV infection , 2010, Retrovirology.
[19] H. Ljunggren,et al. Expansion of Functionally Skewed CD56-Negative NK Cells in Chronic Hepatitis C Virus Infection: Correlation with Outcome of Pegylated IFN-α and Ribavirin Treatment1 , 2009, The Journal of Immunology.
[20] M. Ballmaier,et al. HIV Infection Is Associated with a Preferential Decline in Less-Differentiated CD56dim CD16+ NK Cells , 2009, Journal of Virology.
[21] A. Moretta,et al. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. , 2009, Blood.
[22] Veronica D. Gonzalez,et al. Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. , 2008, Clinical Immunology.
[23] D. Doherty,et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure , 2008, Gut.
[24] R. Lempicki,et al. Innate Immunity in HIV Infection: Enhanced Susceptibility to CD95-Mediated Natural Killer Cell Death and Turnover Induced by HIV Viremia , 2007, Journal of acquired immune deficiency syndromes.
[25] A. Fauci,et al. NK cells in HIV infection: paradigm for protection or targets for ambush , 2005, Nature Reviews Immunology.
[26] P. Klenerman,et al. Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 Infection , 2005, PLoS medicine.
[27] A. Fauci,et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Daucher,et al. Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Gougeon,et al. Cell death and immunity: Apoptosis as an HIV strategy to escape immune attack , 2003, Nature Reviews Immunology.
[30] Nitin J. Karandikar,et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. , 2003, Blood.
[31] M. Caligiuri,et al. The biology of human natural killer-cell subsets. , 2001, Trends in immunology.
[32] G. Fleuren,et al. The Phenotypic Heterogeneity of Human Natural Killer Cells: Presence of at least 48 Different Subsets in the Peripheral Blood , 2001, Scandinavian journal of immunology.
[33] S. von Kleist,et al. A distinct distribution of natural killer cell subgroups in human tissues and blood , 1998, International journal of cancer.
[34] J V Giorgi,et al. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[35] A. Landay,et al. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. , 1995, Cytometry.
[36] R. Jacobs,et al. CD16- CD56+ natural killer cells after bone marrow transplantation. , 1992, Blood.
[37] I Mansour,et al. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset. , 1990, AIDS research and human retroviruses.
[38] H. Tanke,et al. Flow cytometric and morphologic studies of HNK1+ (Leu 7+) lymphocytes in relation to cytomegalovirus carrier status. , 1988, Clinical and experimental immunology.
[39] S. Shahgasempour,et al. Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients. , 2006, Archives of Iranian medicine.
[40] M. Troye-Blomberg,et al. Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination. , 2004, Journal of clinical & laboratory immunology.